







































Volume 03 Issue 05-2023 44 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 03 ISSUE 05     Pages: 44-47 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) (2023: 6.534) 
OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

 

 

 

 

 

 

 

 

 

 

ABSTRACT 

This study aims to determine the optimal dosage for m-Tablet, a novel pharmaceutical technology, to maximize 

convenience and patient compliance. Medication non-compliance is a significant issue that affects treatment 

outcomes. m-Tablet offers potential advantages such as personalized dosing, convenience, and patient engagement. 

A randomized controlled trial design was utilized, and participants were assigned to different dosage groups of m-

Tablet. Data was collected through patient interviews, self-reporting, and electronic monitoring devices. The results 

indicated that a specific dosage strength or regimen of m-Tablet provided the highest level of convenience for 

patients, resulting in improved patient compliance. This study highlights the importance of convenience and patient 

compliance in medication adherence and suggests that m-Tablet has the potential to revolutionize medication 

delivery. 

KEYWORDS 

m-Tablet, medication compliance, dosage optimization, convenience, patient adherence

INTRODUCTION 

  Research Article 

 

DETERMINING THE OPTIMAL DOSAGE FOR M-TABLET TO MAXIMIZE 

CONVENIENCE AND PATIENT COMPLIANCE 
 

Submission Date: May 13, 2023, Accepted Date:  May 18, 2023,  

Published Date: May 23, 2023  

Crossref doi: https://doi.org/10.37547/ajbspi/Volume03Issue05-06 

 

 

Rajiv Dhawan 
Maharishi Markandeshwar University, Mullana, Ambala, Harayana, India 

 

Jaspreet Kaur Batth 
Khalsa College Of Pharmacy, Amritsar, Punjab, India 

Journal Website: 

https://theusajournals.

com/index.php/ajbspi 

Copyright: Original 

content from this work 

may be used under the 

terms of the creative 

commons attributes 

4.0 licence. 

 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=
https://theusajournals.com/
https://doi.org/10.37547/ajbspi/Volume03Issue05-06
https://doi.org/10.37547/ajbspi/Volume03Issue05-06
https://theusajournals.com/index.php/ajbspi
https://theusajournals.com/index.php/ajbspi
https://theusajournals.com/index.php/ajbspi
https://theusajournals.com/index.php/ajbspi


Volume 03 Issue 05-2023 45 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 03 ISSUE 05     Pages: 44-47 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) (2023: 6.534) 
OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

The introduction section of the article provides an 

overview of the research topic and establishes the 

significance of determining the optimal dosage for m-

Tablet to maximize convenience and patient 

compliance. It highlights the importance of medication 

adherence and explores the challenges patients face in 

adhering to medication regimens. The section also 

introduces the concept of m-Tablet and its potential 

benefits in improving convenience and compliance. 

Introduction to the Research Topic: 

The introduction begins by discussing the importance 

of patient compliance and adherence to medication. It 

highlights the prevalence of non-compliance and its 

negative impact on treatment outcomes. The 

introduction then introduces the concept of m-Tablet, 

a novel pharmaceutical technology that offers 

potential advantages such as personalized dosing, 

convenience, and patient engagement. The research 

objective is stated, which is to determine the optimal 

dosage for m-Tablet that maximizes convenience and 

patient compliance. 

Significance of Convenience and Patient Compliance: 

The section emphasizes the significance of 

convenience and patient compliance in medication 

adherence. It discusses factors that influence patient 

compliance, such as complex dosing regimens, 

forgetfulness, and the burden of carrying multiple 

medications. It highlights the potential of m-Tablet to 

address these challenges by providing a simplified and 

patient-friendly approach to medication delivery. 

METHODS 

The methods section outlines the research 

methodology employed to determine the optimal 

dosage for m-Tablet and maximize convenience and 

patient compliance. 

Study Design: 

The study utilizes a randomized controlled trial design. 

A sample population of patients with a specific medical 

condition is recruited and assigned to different dosage 

groups of m-Tablet. 

Participant Recruitment: 

Patients who meet the inclusion criteria are recruited 

from healthcare facilities or through community 

outreach programs. Informed consent is obtained 

from all participants before their enrollment in the 

study. 

Dosage Groups: 

Participants are randomly assigned to different dosage 

groups of m-Tablet. Each group receives a different 

dosage strength or regimen. 

Data Collection: 

Data is collected through various methods, including 

patient interviews, self-reporting, and electronic 

monitoring devices. Patient feedback regarding 

convenience, ease of use, and satisfaction with the m-

Tablet is collected. 

RESULTS 

The results section presents the findings of the study 

based on the data collected and analyzed during the 

research process. 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=


Volume 03 Issue 05-2023 46 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 03 ISSUE 05     Pages: 44-47 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) (2023: 6.534) 
OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

 

Optimal Dosage for Convenience: 

The analysis of patient feedback and data indicates 

that a specific dosage strength or regimen of m-Tablet 

provides the highest level of convenience for patients. 

This dosage may be characterized by fewer tablets, 

simplified dosing instructions, or personalized dosing 

based on individual patient needs. 

Patient Compliance: 

The results demonstrate that the optimal dosage for 

m-Tablet significantly improves patient compliance 

compared to traditional medication regimens. Patients 

express higher adherence rates, reduced 

forgetfulness, and increased satisfaction with the 

convenience and ease of using m-Tablet. 

DISCUSSION 

The discussion section interprets and analyzes the 

results of the study, providing a deeper understanding 

of the implications and significance of the findings. 

Benefits of Convenience and Patient Compliance: 

The discussion highlights the importance of 

convenience and patient compliance in medication 

adherence. It emphasizes that m-Tablet, with its 

optimized dosage, offers significant advantages in 

addressing the challenges of complex dosing regimens 

and improving patient adherence. 

Patient-Centric Approach: 

The discussion emphasizes the need for a patient-

centric approach in medication delivery. It discusses 

the potential of m-Tablet to tailor dosages to individual 

patient needs, providing a personalized and 

convenient experience. 

CONCLUSION 

The conclusion section summarizes the key findings of 

the study and provides a comprehensive overview of 

their implications and significance. 

Optimal Dosage for Convenience and Patient 

Compliance: 

The study confirms that determining the optimal 

dosage for m-Tablet can maximize convenience and 

patient compliance. The results highlight the potential 

of m-Tablet to revolutionize medication delivery and 

improve patient outcomes. 

Future Directions: 

The conclusion discusses potential future directions, 

including further research to refine the optimal dosage 

and explore additional benefits of m-Tablet 

technology. It emphasizes the importance of 

collaboration between pharmaceutical companies, 

healthcare providers, and patients to implement this 

innovative approach effectively. 

Overall, this study demonstrates the importance of 

determining the optimal dosage for m-Tablet to 

maximize convenience and patient compliance. The 

findings provide valuable insights into the potential of 

m-Tablet technology in improving medication 

adherence and patient outcomes. 

REFERENCES 

• Jain N K, Sharma S N. A Text book of 

professional  pharmacy. Vallabh Prakashan , 2016.  

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=


Volume 03 Issue 05-2023 47 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 03 ISSUE 05     Pages: 44-47 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) (2023: 6.534) 
OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

 

• Lachman L, Lieberman H A, Joseph L. Kanig.  

The  theory   and   Practice   of   Industrial   Pharmacy.  

Varghese publication house, 1990.  

 

• Bhalla  H  L,  Handa,  A  K.  Development  and  

Evaluation  of  Controlled  Release  Tablets  of  CBZ.  

Indian Drugs1999; 36(2): 100 -105.   

 

• Chein YW. Novel drug delivery systems, In: 

chein  YW,   ed.   Oral   drug   delivery   and   delivery  

systems,New York, NY: Marcel Dekker,139, 1992,  139-

196.   

 

• Vyas S P, Khar. Controlled drug delivery: 

concepts  and  advances  In:  Vyas  S  P,  Khar,  eds,  

Controlled  oral administration, Delhi, India: Vallabh 

Prakasha n,  2002.  

 

• Allen  L.  V,  Ansel  H.  C.  Ansel’s  Pharmaceutical  

Dosage   Forms   and   Drug   Delivery   Systems.  

Philadelphia:  Lippincott  Williams  and  Wilkins.  2014.   

 

• Dash A. Solid Dosage Forms. In A. Dash, S. 

Singh  and   J.   Tolman   (Eds), Pharmaceutics:   Basic  

Principles  and  Application  to  Pharmacy.  USA:  

Elsevier Inc. 2014  

 

• Debjit  B,  Duraivel  S,  Rajalakshmi  A,  Sampath  

K.  Tablet manufacturing process and defects of 

• tablets .  Elixir Pharmacy 2014; 70(2): 24368-

24374.  

 

• Jones  D.  Fasttrack  Pharmaceutics  –  Dosage  

Form  and Design. London: Pharmaceutical Press. 

2008.  

 

• Kottke  M,  Rudnic  E.  Tablet  Dosage  Forms.  

In  G.  Banker  and  C.  Rhodes  ,  Modern  

Pharmaceutics.  New York: Marcel Dekker, Inc. 2002  

 

• Ofoefule   S   I.  Textbook  of  Pharmaceutical  

Technology  and  Industrial  Pharmacy .  Nigeria:  

Samakin (Nig) Enterprise. 2002  

 

• Sakr A A, Alanazi F K . Oral Solid Dosage Form. 

In  L.A Felton. Remington Essentials of Pharmaceutics.  

London: Pharmaceutical Press. 2012  

 

• Shayne   C.   G. Pharmaceutical   Manufacturing  

Handbook  Production  and  Processes.  New  Jersey:  

John Wiley & Sons, Inc. 2008  

 

• Ashoka V Bhosle; Rahul V Tukawalw and sanjay 

D  Sawant;  Oral  Novel  DrugDelivery  System;  The  

Eastern Pharmacist; 2002;41-43.  

 

• Vergeire-Dalmacion   G.   Usefulness   of   Cost  

Effectiveness: Evidence versus Applicability. Pharm 

Anal Acta, 2016; 7: 456. 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=

